DNA
Income statement / Annual
Last year (2023), Ginkgo Bioworks Holdings, Inc.'s total revenue was $251.46 M,
a decrease of 47.36% from the previous year.
In 2023, Ginkgo Bioworks Holdings, Inc.'s net income was -$892.87 M.
See Ginkgo Bioworks Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2001
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2001 |
| Operating Revenue |
$251.46 M
|
$477.71 M
|
$313.84 M
|
$76.66 M
|
$54.18 M
|
$98.29 M
|
| Cost of Revenue |
$54.01 M |
$204.22 M |
$129.69 M |
$15.61 M |
$0.00 |
$0.00 |
| Gross Profit |
$197.45 M |
$273.49 M |
$184.15 M |
$61.05 M |
$54.18 M |
$98.29 M |
| Gross Profit Ratio |
0.79 |
0.57 |
0.59 |
0.8 |
1 |
1 |
| Research and Development
Expenses |
$580.62 M
|
$1.05 B
|
$1.15 B
|
$159.77 M
|
$96.30 M
|
$100.48 M
|
| General & Administrative
Expenses |
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
$77.39 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
$77.39 M
|
| Other Expenses |
$96.21 M |
$7.63 M |
-$1.73 M |
$16.13 M |
$1.57 M |
$0.00 |
| Operating Expenses |
$1.11 B |
$2.48 B |
$2.01 B |
$198.07 M |
$125.78 M |
$177.87 M |
| Cost And Expenses |
$1.12 B |
$2.69 B |
$2.14 B |
$213.68 M |
$125.78 M |
$177.87 M |
| Interest Income |
$57.22 M |
$20.26 M |
$837,000.00 |
$2.58 M |
$5.76 M |
$0.00 |
| Interest Expense |
$93,000.00 |
$106,000.00 |
$2.37 M |
$2.39 M |
$2.42 M |
$0.00 |
| Depreciation &
Amortization |
$71.55 M
|
$61.63 M
|
$29.08 M
|
$13.86 M
|
$10.76 M
|
$14.80 M
|
| EBITDA |
-$821.29 M
|
-$2.06 B
|
-$1.81 B
|
-$108.59 M
|
-$106.66 M
|
-$219.71 M
|
| EBITDA Ratio |
-3.27 |
-4.56 |
-5.98 |
-1.4 |
-1.5 |
-2.24 |
| Operating Income Ratio
|
-3.44
|
-4.62
|
-5.83
|
-1.79
|
-1.32
|
-2.39
|
| Total Other
Income/Expenses Net |
-$28.53 M
|
$87.55 M
|
-$9.66 M
|
$12.19 M
|
-$48.24 M
|
$0.00
|
| Income Before Tax |
-$892.94 M |
-$2.12 B |
-$1.84 B |
-$124.83 M |
-$119.84 M |
$0.00 |
| Income Before Tax Ratio
|
-3.55
|
-4.44
|
-5.86
|
-1.63
|
-2.21
|
0
|
| Income Tax Expense |
-$71,000.00 |
-$15.03 M |
-$1.48 M |
$1.89 M |
$22,000.00 |
$0.00 |
| Net Income |
-$892.87 M |
-$2.10 B |
-$1.83 B |
-$126.61 M |
-$119.33 M |
$0.00 |
| Net Income Ratio |
-3.55 |
-4.41 |
-5.83 |
-1.65 |
-2.2 |
0 |
| EPS |
-18.37 |
-50.15 |
-53.83 |
-0.0853 |
-0.0804 |
0 |
| EPS Diluted |
-18.37 |
-50.12 |
-53.81 |
-0.0853 |
-0.0804 |
0 |
| Weighted Average Shares
Out |
$48.61 M
|
$41.98 M
|
$34.00 M
|
$1.49 B
|
$1.49 B
|
$0.00
|
| Weighted Average Shares
Out Diluted |
$48.61 M
|
$42.00 M
|
$34.01 M
|
$1.49 B
|
$1.49 B
|
$0.00
|
| Link |
|
|
|
|
|
|
